2025-10-15T12:22:35-07:00 2024-12-31 521185156 Lydon Fetterolf Corydon PA 9401 Key West Avenue Rockville MD 20850 990 2024-01-01 521983273 Friends of Cancer Research FRIE 2029446700 1800 M Street NW 1050S Washington DC 20036 Jeff Allen PhD President & CEO 2025-10-15 true true Jeff Corydon IV CPA CFP P00297218 3019484400 2024 2025-03-06 01:10:19Z Jeff Allen PhD 1800 M Street NW 1050S Washington DC 20036 7499449 false X WWW.FOCR.ORG X 1996 DC TO DRIVE COLLABORATION AMONG PARTNERS FROM EVERY HEALTHCARE SECTOR TO POWER ADVANCES IN SCIENCE, POLICY AND REGULATION THAT SPEED LIFE-SAVING TREATMENTS TO PATIENTS. 15 14 16 15 0 6891086 6949510 0 295644 549939 0 7186730 7499449 0 0 2755003 3021050 0 1064060 2490004 2750144 5245007 5771194 1941723 1728255 19663708 23104598 3827913 4290909 15835795 18813689 X TO DRIVE COLLABORATION AMONG PARTNERS FROM EVERY HEALTHCARE SECTOR TO POWER ADVANCES IN SCIENCE, POLICY AND REGULATION THAT SPEED LIFE-SAVING TREATMENTS TO PATIENTS. false false 2442055 Science Policy: Friends of Cancer Research drives collaboration among partners from every healthcare sector to power advances in science, policy and regulation that speed life-saving treatments to patients. Master Protocols present opportunities to improve clinical trial efficiencies and more accessible for patients. This includes the Lung-MAP study, a unique, collaborative cancer clinical trial that uses genetic screening to match patients to investigational new treatments for non-small cell lung cancers. 545160 Communication: THE Organization PROVIDES INDEPTH COVERAGE OF THE EVENTS, TRENDS, AND ISSUES THAT AFFECT the public healthcare INDUSTRY. 510658 Meetings and Professional Development: Friends of Cancer Research brings together leaders in cancer drug development, federal health and regulatory agencies, academic research, the private sector, and patient advocates for focused discussions on key issues surrounding the development and regulation of cancer drugs and therapies. 112624 Patient Advocacy Training: Patient advocacy encompasses engaging, educating and empowering patients through ProgressforPatients.org and Project TEACH which empowers Black women through education and outreach to participate in and effectively engage with researchers and clinicians. 112624 3610497 true true false false false false false false false false true false false true true true true false false false false false false false false false false false false true false false false false false false false false false true false false false false false false false true 12 0 true 16 true false false false false false false false 0 false false false false false false false X 15 14 false false false false false false false true false false false true true true true true true true true false DC VA X X Friends of Cancer Research 2029446700 1800 M Street NW 1050S Washington DC 20036 Jeff Allen PhD President & CEO 40.00 0.00 X X 644527 0 121824 Ryan Hohman JD VP-Public Affairs 40.00 0.00 299686 0 23972 Mark Stewart PhD VP-Science Policy 40.00 0.00 286475 0 21465 Heather Chaney VP-Operations 40.00 0.00 214521 0 24481 Hillary Andrews Dir.-Reg & Res Par 40.00 0.00 179111 0 24224 linda ostermann Dir.-Grant & Oper 40.00 0.00 154088 0 21809 Brittany McKelvey Dir.-Reg Affairs 40.00 0.00 142236 0 6637 Finnian Galloway-Kane Dir-Pub Relations 40.00 0.00 113418 0 14378 Pennie Abramson PhD Director 0.50 0.00 X 0 0 0 Carolyn Aldige Director 0.50 0.00 X 0 0 0 Anna D Barker PhD Secretary 0.50 0.00 X X 0 0 0 Edward Sanghyun Kim MD MBA Director 0.50 0.00 X 0 0 0 Roy Herbst MD PhD Director 0.50 0.00 X 0 0 0 Ellen Sigal PhD Chair & Founder 0.50 0.00 X X 0 0 0 Marlene Malek RN Vice Chair 0.50 0.00 X X 0 0 0 Sudip Parikh PhD Treasurer 0.50 0.00 X X 0 0 0 Margaret Foti PhD MD Executive Dir. 0.50 0.00 X 0 0 0 David Mitchell Executive Dir. 0.50 0.00 X 0 0 0 Richard Schilsky MD Executive Dir. 0.50 0.00 X 0 0 0 Elizabeth Thompson Director 0.50 0.00 X 0 0 0 Edward J Benz Jr MD Director 0.50 0.00 X 0 0 0 Margaret Anderson Director 0.50 0.00 X 0 0 0 2034062 258790 8 false true false Delcor Technology Solutions Inc 8380 Colesville Rd 550 Silver Spring MD 20910 Consulting 101903 sandi r hoffman llc 1101 wootton pkwy ste 900a rockville MD 20852 consulting 441109 Four Moon Productions 90 Corporate Park Dr Ste 110 Henderson NV 89074 Media/Audio/Broadcasting 214356 Lydon Fetterolf Corydon PA 9401 Key West Ave Rockville MD 20850 Accounting 129161 Cancer Research and Biostatistics 1505 Westlake Ave N Ste 750 Seattle WA 98109 Project Consulting 235625 5 6949510 18000 6949510 0 549939 549939 0 0 0 0 0 0 0 0 7499449 549939 0 0 0 0 1636845 1144136 329267 163442 0 1122473 814329 194365 113779 37442 26209 7488 3745 61239 14365 42045 4829 163051 112640 34548 15863 0 62155 220 61825 110 121641 430 120996 215 0 0 76063 76063 382657 374257 8400 0 139220 97313 28006 13901 0 0 382528 267382 76950 38196 65708 60598 4212 898 0 1060405 409294 651111 0 0 69416 48522 13963 6931 0 Dues and Subscriptions 165353 106853 35895 22605 Contributions-other 56000 56000 Printing and Publications 55488 32989 1709 20790 Miscellaneous expense 48653 9469 36507 2677 64857 35491 24398 4968 5771194 3610497 1096637 1064060 271625 1014331 391891 511433 535000 965001 150666 193652 0 0 0 0 138892 130775 730201 635272 146345 94929 14484659 16588415 0 0 0 3544630 3606062 19663708 23104598 218632 237669 3609281 4053240 3827913 4290909 X 14707045 17036189 1128750 1777500 15835795 18813689 19663708 23104598 1728255 1249639 X false true X true false X 4633439 4786512 6455557 6891086 6949510 29716104 0 0 4633439 4786512 6455557 6891086 6949510 29716104 0 29716104 131323 295796 339036 383541 549939 1699635 0 1979 5663 7642 31423381 0.94570 0.95260 X RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED 120446 120446 77983 45878 32105 531772 468948 62824 94929 457 Plan Asset 271261 Deposits 30982 Right of Use Asset 3303819 3606062 457 Plan Liability 271261 Lease Liability 3781979 4053240 X 8673025 1249639 1249639 7423386 76063 76063 7499449 5695131 5695131 76063 76063 5771194 Part X : FIN48 Footnote THE ORGANIZATION IS EXEMPT FROM INCOME TAX UNDER SECTION 501(C)(3) OF THE INTERNAL REVENUE CODE. INCOME FROM NONEXEMPT FUNCTIONS IS SUBJECT TO UNRELATED BUSINESS INCOME TAXES TO THE EXTENT THAT THE REVENUE EXCEEDS RELATED COSTS. THE ORGANIZATION INCURRED $0 OF UNRELATED BUSINESS INCOME TAXES FOR THE YEAR ENDED DECEMBER 31, 2024. IN ADDITION, THE ORGANIZATION QUALIFIES FOR THE CHARITABLE CONTRIBUTION DEDUCTION UNDER SECTION 170 AND HAS BEEN CLASSIFIED AS AN ORGANIZATION OTHER THAN A PRIVATE FOUNDATION UNDER SECTION 509(C)(2).THE ORGANIZATION FOLLOWS THE ACCOUNTING STANDARD ON ACCOUNTING FOR UNCERTAINTY IN INCOME TAXES, WHICH ADDRESSES THE DETERMINATION OF WHETHER TAX BENEFITS CLAIMED OR EXPECTED TO BE CLAIMED ON A TAX RETURN SHOULD BE RECORDED IN THE FINANCIAL STATEMENTS. UNDER THIS GUIDANCE, THE ORGANIZATION MAY RECOGNIZE THE TAX BENEFIT FROM AN UNCERTAIN TAX POSITION ONLY IF IT IS MORE LIKELY THAN NOT THAT THE TAX POSITION WILL BE SUSTAINED ON EXAMINATION BY TAXING AUTHORITIES, BASED ON THE TECHNICAL MERITS OF THE POSITION. THE TAX BENEFITS RECOGNIZED IN THE FINANCIAL STATEMENTS FROM SUCH A POSITION ARE MEASURED BASED ON THE LARGEST BENEFIT THAT HAS A GREATER THAN 50% LIKELIHOOD OF BEING REALIZED UPON ULTIMATE SETTLEMENT. THE GUIDANCE ON ACCOUNTING FOR UNCERTAINTY IN INCOME TAXES ALSO ADDRESSES DE-RECOGNITION, CLASSIFICATION, INTEREST, AND PENALTIES ON INCOME TAXES, AND ACCOUNTING IN INTERIM PERIODS.MANAGEMENT EVALUATED THE ORGANIZATION'S TAX POSITIONS AND CONCLUDED THAT THE ORGANIZATION HAD TAKEN NO UNCERTAIN TAX POSITIONS THAT REQUIRE ADJUSTMENT TO THE FINANCIAL STATEMENT TO COMPLY WITH THE PROVISIONS OF THIS GUIDANCE. CURRENTLY, THE TAX YEARS OPEN AND SUBJECT TO EXAMINATION BY THE INTERNAL REVENUE SERVICE ARE 2021, 2022, AND 2023 TAX YEARS. X X false false false false false false false false false Heather Chaney VP-Operations 202521 12000 8705 15776 239002 Hillary Andrews Dir.-Reg & Res Par 169111 10000 7292 16932 203335 Jeff Allen PhD President & CEO 594527 50000 88800 33024 766351 linda ostermann Dir.-Grant & Oper 148088 6000 6283 15526 175897 Mark Stewart PhD VP-Science Policy 261475 25000 9243 12222 307940 Ryan Hohman JD VP-Public Affairs 286686 13000 12086 11886 323658 X 2 18000 Appraisal false false false Form 990, Part VI, Section B, Line 11b The Board Chair and the president & CEO reviews a draft of the form 990 before filing the final copy with the IRS. Form 990, Part VI, Section C, Line 19 FRIENDS OF CANCER RESEARCH MAKES ITS GOVERNING DOCUMENTS, CONFLICT OF INTEREST POLICY, PRIVACY POLICY, WHISTLEBLOWER POLICY AND AUDITED FINANCIAL STATEMENTS PUBLICLY AVAILABLE ON ITS WEBSITE at: https://www.focr.org/financials-policies